康希諾生物(06185.HK)DTcP疫苗啟動III期臨床試驗

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

康希諾生物(06185.HK)DTcP疫苗啟動III期臨床試驗

阿思達克 08-13 23:46

康希諾生物(06185.HK)公布，集團開發的嬰幼兒用DTcP疫苗(2歲以下)近日正式啟動III期臨床試驗，並完成首例受試者入組。公司的嬰幼兒用DTcP為組分百白破疫苗，目前暫無國內疫苗廠商研發的組分百白破疫苗獲批上市。

康希諾生物(06185.HK)

Relevant Stocks

康希諾生物(06185.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

康希諾生物(06185.HK)DTcP疫苗啟動III期臨床試驗

Services

About Us

Agreement Statement